News

Filter

Current filters:

TargretinPharmaceutical

Eisai licenses bexarotene to Minophagen forJapan; Roche opts for Invida for Korean marketing

04-04-2011

Japanese drug major Eisai (TYO: 4532) has granted a license Minophagen Pharmaceutical, based in Tokyo,…

Asia-PacificbexaroteneEisaiInvidaLicensingMinophagenOncologyPharmaceuticalRocheTargretin

Back to top